Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 15/20 | 0.42 |
| ▸ | WDR77 | Q9BQA1 | 15/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9206928 | 0.98 | PRMT5 (0.40) | PRMT5WDR77RAB9A | |
| SCHEMBL9210433 | 0.91 | PRMT5 (0.41) | PRMT5WDR77 | |
| SCHEMBL9206696 | 0.90 | PRMT5 (0.38) | PRMT5WDR77RAB9A | |
| SCHEMBL9742144 | 0.90 | PRMT5 (0.43) | PRMT5WDR77 | |
| SCHEMBL9211468 | 0.89 | PRMT5 (0.41) | PRMT5WDR77 | |
| Hydrochloric Acid SCHEMBL9215883 | 0.89 | PRMT5 (0.43) | PRMT5WDR77 | |
| Hydrochloric Acid SCHEMBL9212963 | 0.89 | PRMT5 (0.40) | PRMT5WDR77 | |
| SCHEMBL9206642 | 0.89 | PRMT5 (0.40) | PRMT5WDR77 | |
| SCHEMBL9213257 | 0.88 | PRMT5 (0.42) | PRMT5WDR77 | |
| Hydrochloric Acid SCHEMBL9215384 | 0.88 | PRMT5 (0.40) | PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0292840-B1 | Cyclic amine derivatives, medicaments containing these compounds and procedure for their preparation | THOMAE GMBH DR K (DE) | 1995-08-09 | — | — | EP | disclosed |
| US-5175157-A | Cardiovascular disorders | BOEHRINGER INGELHEIM GMBH (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0292840-A2 | Cyclic amine derivatives, medicaments containing these compounds and procedure for their preparation | Dr. Karl Thomae GmbH (DE) | 1988-11-30 | — | — | EP | disclosed |